Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform ...

Krebs Biochemicals & Industries Ltd share price was up by 2.06% from the previous closing price of ₹90.64. Who are peers of Krebs Biochemicals & Industries Ltd? The peers of Krebs Biochemicals ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals, such as ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Revenues Increased 19% Over the Third Quarter of 2023CUPERTINO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a ...

Now, he has showcased his business acumen 14 years after co-founding GF Biochemicals. Flamini owns 60% of the shares in the ...

KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve Intimation of Board ...

The UPM Biochemicals has collaborated with Selenis, and Bormioli Pharma to produce BioPET bottles made from partially ...

The base was neutralized by addition of 2 μl of 1 N HCl, and the DNA fragments were phosphorylated in 1× T4 ligase buffer (US Biochemicals, USB; Cleveland, OH) in a total of 20 μl for 30 min at ...

Former Arsenal midfielder Mathieu Flamini, now a billionaire, has previously hinted at the possibility of owning the Gunners ...